Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
META
Meta Platforms
$647.49
Chart
$484.66 (+33.60%)
$625.66 (+3.49%)
$674.33 (-3.98%)
$504.16 (+28.43%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
META
Meta Platforms
Current Price
$647.49
Login to view Meta Platforms (META) recommendation from the last 90 days from financial news and social media.
Chart
$484.66 (+33.60%)
$625.66 (+3.49%)
$674.33 (-3.98%)
$504.16 (+28.43%)
META Latest Headlines
Notable Friday Option Activity: META BHF VEL. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Meta Platforms Inc (Symbol: META) where a total volume of 302923 contracts has been traded thus far today a contract volume which is representative of approxi
Today
Daily Dividend Report: METAWCCDLRZBHEOG. The Meta Platforms board of directors today declared a quarterly cash dividend of $0.525 per share of the companys outstanding Class A common stock and Class B common stock payable on June 26 2025 to stockholders of record as of the close of business on June 16 2025.The Bo
Today
Daily Dividend Report: METAWCCDLRZBHEOG. The Meta Platforms board of directors today declared a quarterly cash dividend of $0.525 per share of the companys outstanding Class A common stock and Class B common stock payable on June 26 2025 to stockholders of record as of the close of business on June 16 2025.The Bo
Today
Inquiry Into Meta Platformss Competitor Dynamics In Interactive Media &. Services Industry. In today'.s rapidly changing and highly competitive business world it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article we will undertake a comprehensive industry comparison evaluating Meta Platforms (NASDAQ:) vis-à-vis its key competitors in the Interactive Media &. Services industry. Through a detailed analysis of
Today
Inquiry Into Meta Platformss Competitor Dynamics In Interactive Media &. Services Industry. In today'.s rapidly changing and highly competitive business world it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article we will undertake a comprehensive industry comparison evaluating Meta Platforms (NASDAQ:) vis-à-vis its key competitors in the Interactive Media &. Services industry. Through a detailed analysis of
Today
Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer. MONMOUTH JUNCTION N.J. May 30 2025 /PRNewswire/ -- Creatv Bio a Division of Creatv MicroTech Inc. (Creatv) in collaboration with CytoDyn Inc. (CytoDyn) presents promising four-year survival rates from a pooled clinical trial analysis of patients with metastatic triple-negative...
Today
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer. ®. Inc. a clinical-stage biopharmaceutical company focused on the development of SYNC-T an in situ personalized combination immunotherapy platform optimized for solid tumor cancers today announced that the first patient has been successfully dosed in the LEGION-100 trial a two-part Phase 2a Dose Escalation and Dose Optimization tr
Today
Peter Lynch Detailed Fundamental Analysis - META. Below is Valideas guru fundamental report for META PLATFORMS INC (META). Of the 22 guru strategies we follow META rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price rela
Today
Mark Zuckerberg Already Made It To Step 1 By Naming His Goat Bitcoin — Now Investor Dials Meta To Ask Him To Add BTC To Companys Reserves. ) on Wednesday to buy BTC) for its balance sheet.
Today
Meta Announces Quarterly Cash Dividend. ) board of directors today declared a quarterly cash dividend of ...
Thu May 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
META Stock trends
META Stock performance
META Stock analysis
META investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Hover over the category for more information
